通过抑制胃癌细胞分泌 MIF,限制蛋氨酸可促进巨噬细胞向 M1 分化,并促进 PD-L1/PD-1 阻断剂的免疫治疗效果。

IF 5 2区 医学 Q2 Medicine Translational Oncology Pub Date : 2024-11-13 DOI:10.1016/j.tranon.2024.102181
Lin Xin , Jiang Liu , Jun-Yan Lai , He-Song Xu , Luo-Jun Fan , Yong-Hui Zou , Qi Zhou , Zhen- Qi Yue , Jin-Heng Gan
{"title":"通过抑制胃癌细胞分泌 MIF,限制蛋氨酸可促进巨噬细胞向 M1 分化,并促进 PD-L1/PD-1 阻断剂的免疫治疗效果。","authors":"Lin Xin ,&nbsp;Jiang Liu ,&nbsp;Jun-Yan Lai ,&nbsp;He-Song Xu ,&nbsp;Luo-Jun Fan ,&nbsp;Yong-Hui Zou ,&nbsp;Qi Zhou ,&nbsp;Zhen- Qi Yue ,&nbsp;Jin-Heng Gan","doi":"10.1016/j.tranon.2024.102181","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>The limited curative effect of PD-L1/PD-1 blockades presents challenges to immunotherapy for advanced gastric cancer. We have found that methionine restriction (MR) enhances the drug resistance of gastric carcinoma cells. We aimed to explore whether MR can enhance the efficacy of PD-L1/PD-1 blockades in gastric cancer.</div></div><div><h3>Methods</h3><div>To conduct MR, gastric carcinoma cells were transfected with LV-METase in vitro, and 615 mice were injected with MFC cells with stable METase expression in vivo. Flow cytometry was conducted to measure the proportions of M1/M2 macrophages and CD8<sup>+</sup> GZMB<sup>+</sup>/IFN-γ<sup>+</sup> T cells. Additionally, the levels of M1/M2 macrophage markers and MIF were also detected.</div></div><div><h3>Results</h3><div>MR increased M1 and down-regulated M2 macrophages. MR suppressed MIF levels in gastric carcinoma cells, while the addition of anti-MIF neutralizing antibody inhibited the effect of MR on macrophage M1/M2 polarization. MR enhanced the increase of the proportion of CD8<sup>+</sup> GZMB<sup>+</sup> T cells and CD8<sup>+</sup> IFN-γ<sup>+</sup> T cells induced by PD-L1/PD-1 blockades. In vivo detection verified the efficacy of the combination of MR and PD-L1/PD-1 blockades on gastric cancer.</div></div><div><h3>Conclusions</h3><div>MR inhibits the secretion of MIF by gastric carcinoma cells, promotes macrophage M1 polarization, and enhances the therapeutic effect of PD-L1/PD-1 blockades in gastric cancer.</div></div>","PeriodicalId":48975,"journal":{"name":"Translational Oncology","volume":"51 ","pages":"Article 102181"},"PeriodicalIF":5.0000,"publicationDate":"2024-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Methionine restriction promotes the polarization of macrophages towards M1 and the immunotherapy effect of PD-L1/PD-1 blockades by inhibiting the secretion of MIF by gastric carcinoma cells\",\"authors\":\"Lin Xin ,&nbsp;Jiang Liu ,&nbsp;Jun-Yan Lai ,&nbsp;He-Song Xu ,&nbsp;Luo-Jun Fan ,&nbsp;Yong-Hui Zou ,&nbsp;Qi Zhou ,&nbsp;Zhen- Qi Yue ,&nbsp;Jin-Heng Gan\",\"doi\":\"10.1016/j.tranon.2024.102181\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>The limited curative effect of PD-L1/PD-1 blockades presents challenges to immunotherapy for advanced gastric cancer. We have found that methionine restriction (MR) enhances the drug resistance of gastric carcinoma cells. We aimed to explore whether MR can enhance the efficacy of PD-L1/PD-1 blockades in gastric cancer.</div></div><div><h3>Methods</h3><div>To conduct MR, gastric carcinoma cells were transfected with LV-METase in vitro, and 615 mice were injected with MFC cells with stable METase expression in vivo. Flow cytometry was conducted to measure the proportions of M1/M2 macrophages and CD8<sup>+</sup> GZMB<sup>+</sup>/IFN-γ<sup>+</sup> T cells. Additionally, the levels of M1/M2 macrophage markers and MIF were also detected.</div></div><div><h3>Results</h3><div>MR increased M1 and down-regulated M2 macrophages. MR suppressed MIF levels in gastric carcinoma cells, while the addition of anti-MIF neutralizing antibody inhibited the effect of MR on macrophage M1/M2 polarization. MR enhanced the increase of the proportion of CD8<sup>+</sup> GZMB<sup>+</sup> T cells and CD8<sup>+</sup> IFN-γ<sup>+</sup> T cells induced by PD-L1/PD-1 blockades. In vivo detection verified the efficacy of the combination of MR and PD-L1/PD-1 blockades on gastric cancer.</div></div><div><h3>Conclusions</h3><div>MR inhibits the secretion of MIF by gastric carcinoma cells, promotes macrophage M1 polarization, and enhances the therapeutic effect of PD-L1/PD-1 blockades in gastric cancer.</div></div>\",\"PeriodicalId\":48975,\"journal\":{\"name\":\"Translational Oncology\",\"volume\":\"51 \",\"pages\":\"Article 102181\"},\"PeriodicalIF\":5.0000,\"publicationDate\":\"2024-11-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Translational Oncology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1936523324003073\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Translational Oncology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1936523324003073","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

背景:PD-L1/PD-1阻断剂的疗效有限,这给晚期胃癌的免疫疗法带来了挑战。我们发现蛋氨酸限制(MR)会增强胃癌细胞的耐药性。我们的目的是探讨 MR 能否增强 PD-L1/PD-1 阻断剂在胃癌中的疗效:为了进行MR研究,我们在体外用LV-METase转染了胃癌细胞,并在体内给615只小鼠注射了稳定表达METase的MFC细胞。流式细胞术测量了 M1/M2 巨噬细胞和 CD8+ GZMB+/IFN-γ+ T 细胞的比例。此外,还检测了 M1/M2 巨噬细胞标记物和 MIF 的水平:结果:MR增加了M1巨噬细胞,下调了M2巨噬细胞。MR抑制了胃癌细胞中的MIF水平,而加入抗MIF中和抗体则抑制了MR对巨噬细胞M1/M2极化的影响。MR增强了PD-L1/PD-1阻断剂诱导的CD8+ GZMB+ T细胞和CD8+ IFN-γ+ T细胞比例的增加。体内检测验证了MR和PD-L1/PD-1阻断剂联合使用对胃癌的疗效:结论:MR能抑制胃癌细胞分泌MIF,促进巨噬细胞M1极化,增强PD-L1/PD-1阻断剂对胃癌的治疗效果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Methionine restriction promotes the polarization of macrophages towards M1 and the immunotherapy effect of PD-L1/PD-1 blockades by inhibiting the secretion of MIF by gastric carcinoma cells

Background

The limited curative effect of PD-L1/PD-1 blockades presents challenges to immunotherapy for advanced gastric cancer. We have found that methionine restriction (MR) enhances the drug resistance of gastric carcinoma cells. We aimed to explore whether MR can enhance the efficacy of PD-L1/PD-1 blockades in gastric cancer.

Methods

To conduct MR, gastric carcinoma cells were transfected with LV-METase in vitro, and 615 mice were injected with MFC cells with stable METase expression in vivo. Flow cytometry was conducted to measure the proportions of M1/M2 macrophages and CD8+ GZMB+/IFN-γ+ T cells. Additionally, the levels of M1/M2 macrophage markers and MIF were also detected.

Results

MR increased M1 and down-regulated M2 macrophages. MR suppressed MIF levels in gastric carcinoma cells, while the addition of anti-MIF neutralizing antibody inhibited the effect of MR on macrophage M1/M2 polarization. MR enhanced the increase of the proportion of CD8+ GZMB+ T cells and CD8+ IFN-γ+ T cells induced by PD-L1/PD-1 blockades. In vivo detection verified the efficacy of the combination of MR and PD-L1/PD-1 blockades on gastric cancer.

Conclusions

MR inhibits the secretion of MIF by gastric carcinoma cells, promotes macrophage M1 polarization, and enhances the therapeutic effect of PD-L1/PD-1 blockades in gastric cancer.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
8.40
自引率
2.00%
发文量
314
审稿时长
54 days
期刊介绍: Translational Oncology publishes the results of novel research investigations which bridge the laboratory and clinical settings including risk assessment, cellular and molecular characterization, prevention, detection, diagnosis and treatment of human cancers with the overall goal of improving the clinical care of oncology patients. Translational Oncology will publish laboratory studies of novel therapeutic interventions as well as clinical trials which evaluate new treatment paradigms for cancer. Peer reviewed manuscript types include Original Reports, Reviews and Editorials.
期刊最新文献
Clinical efficacies of different neoadjuvant therapies for non-small cell lung cancer Integrated multi-omics demonstrates enhanced antitumor efficacy of donafenib combined with FADS2 inhibition in hepatocellular carcinoma Disruption of bioenergetics enhances the radio-sensitivity of patient-derived glioblastoma tumorspheres KRas plays a negative role in regulating IDO1 expression Comparative transcriptomic analysis uncovers molecular heterogeneity in hepatobiliary cancers
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1